Moderna, Inc. Common Stock MRNA

$190.01 +0.57% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K 8-K 2026-09-30 View →
4 PRIMARY DOCUMENT 2026-09-16 View →
4 PRIMARY DOCUMENT 2026-09-14 View →
4 PRIMARY DOCUMENT 2026-09-08 View →
4 PRIMARY DOCUMENT 2026-09-08 View →
4 PRIMARY DOCUMENT 2026-09-03 View →
4 PRIMARY DOCUMENT 2026-09-03 View →
4 PRIMARY DOCUMENT 2026-09-03 View →
8-K 8-K 2026-09-01 View →
4 PRIMARY DOCUMENT 2026-08-31 View →
4 PRIMARY DOCUMENT 2026-08-31 View →
4 PRIMARY DOCUMENT 2026-08-31 View →
4 PRIMARY DOCUMENT 2026-08-07 View →
10-Q 10-Q 2026-07-31 View →
8-K 8-K 2026-07-31 View →
4 PRIMARY DOCUMENT 2026-07-16 View →
4 PRIMARY DOCUMENT 2026-07-10 View →
8-K 8-K 2026-07-08 View →
4 PRIMARY DOCUMENT 2026-07-07 View →
4 PRIMARY DOCUMENT 2026-07-06 View →
4 PRIMARY DOCUMENT 2026-06-17 View →
4 PRIMARY DOCUMENT 2026-06-08 View →
4 PRIMARY DOCUMENT 2026-06-08 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 PRIMARY DOCUMENT 2026-06-03 View →
4 PRIMARY DOCUMENT 2026-05-29 View →
4 PRIMARY DOCUMENT 2026-05-29 View →
4 PRIMARY DOCUMENT 2026-05-29 View →
4 4 2026-05-22 View →
4 PRIMARY DOCUMENT 2026-05-18 View →
8-K 8-K 2026-05-11 View →
4 PRIMARY DOCUMENT 2026-05-08 View →
4 PRIMARY DOCUMENT 2026-05-08 View →
4 PRIMARY DOCUMENT 2026-05-08 View →
4 PRIMARY DOCUMENT 2026-05-08 View →
4 PRIMARY DOCUMENT 2026-05-08 View →
4 PRIMARY DOCUMENT 2026-05-08 View →
4 PRIMARY DOCUMENT 2026-05-08 View →
4 PRIMARY DOCUMENT 2026-05-04 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$190.01
Market Cap
$75.86 billion
52-Week Range
$22.28 – $208.90
Average Volume
20.21 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.